FEDI, SANDRA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.867
EU - Europa 6.505
AS - Asia 3.148
SA - Sud America 347
AF - Africa 111
OC - Oceania 99
Continente sconosciuto - Info sul continente non disponibili 64
Totale 19.141
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.716
PL - Polonia 1.992
RU - Federazione Russa 1.581
SG - Singapore 961
IT - Italia 896
CN - Cina 635
HK - Hong Kong 450
IE - Irlanda 447
SE - Svezia 422
UA - Ucraina 348
VN - Vietnam 321
KR - Corea 320
DE - Germania 287
BR - Brasile 277
FI - Finlandia 172
FR - Francia 158
GB - Regno Unito 122
IN - India 101
AU - Australia 98
CA - Canada 91
TR - Turchia 83
JP - Giappone 72
JO - Giordania 35
BD - Bangladesh 29
AR - Argentina 24
CI - Costa d'Avorio 24
ID - Indonesia 24
MX - Messico 23
IQ - Iraq 22
ZA - Sudafrica 19
CH - Svizzera 16
SC - Seychelles 16
EC - Ecuador 15
PK - Pakistan 14
NL - Olanda 13
PH - Filippine 13
ES - Italia 11
VE - Venezuela 11
EG - Egitto 10
CR - Costa Rica 9
SA - Arabia Saudita 9
TH - Thailandia 9
DZ - Algeria 8
TN - Tunisia 8
AE - Emirati Arabi Uniti 7
JM - Giamaica 7
MA - Marocco 7
AT - Austria 6
CZ - Repubblica Ceca 6
NG - Nigeria 6
TW - Taiwan 6
BJ - Benin 5
BO - Bolivia 5
CL - Cile 5
GR - Grecia 4
KE - Kenya 4
KZ - Kazakistan 4
MY - Malesia 4
OM - Oman 4
TT - Trinidad e Tobago 4
BG - Bulgaria 3
GT - Guatemala 3
HN - Honduras 3
HU - Ungheria 3
LV - Lettonia 3
MM - Myanmar 3
PY - Paraguay 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
UY - Uruguay 3
UZ - Uzbekistan 3
AZ - Azerbaigian 2
BE - Belgio 2
CO - Colombia 2
DO - Repubblica Dominicana 2
GE - Georgia 2
LB - Libano 2
LT - Lituania 2
MN - Mongolia 2
NI - Nicaragua 2
NP - Nepal 2
PE - Perù 2
SY - Repubblica araba siriana 2
AL - Albania 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BZ - Belize 1
CY - Cipro 1
DK - Danimarca 1
DM - Dominica 1
EE - Estonia 1
ET - Etiopia 1
GP - Guadalupe 1
HT - Haiti 1
IR - Iran 1
KH - Cambogia 1
KW - Kuwait 1
MQ - Martinica 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
Totale 19.070
Salva come PNG Salva come JPEG
Città #
Warsaw 1.991
Santa Clara 1.513
Ashburn 806
Fairfield 767
Singapore 676
Jacksonville 543
Chandler 479
Dublin 445
Hong Kong 359
Seattle 345
Woodbridge 345
Seoul 315
Wilmington 294
San Jose 283
Cambridge 276
Houston 275
Milan 188
Los Angeles 167
Council Bluffs 152
Beijing 146
Buffalo 127
Hefei 123
Princeton 109
Ann Arbor 101
Dallas 100
Boardman 99
Lauterbourg 97
Boston 94
Ho Chi Minh City 80
The Dalles 79
Altamura 75
Melbourne 74
Hanoi 72
Mumbai 71
Rome 68
Lawrence 62
Columbus 53
Tokyo 51
Munich 50
New York 45
Moscow 44
Helsinki 42
Medford 39
Phoenix 39
Kent 38
Shanghai 36
Florence 31
Naples 31
San Diego 27
London 25
Abidjan 24
Paris 24
Da Nang 23
São Paulo 23
Dong Ket 22
Izmir 22
Turku 22
Montreal 21
Norwalk 21
Frankfurt Am Main 20
Hillsboro 20
Auburn Hills 19
Figino 19
Orem 17
Verona 17
Chicago 16
Jakarta 16
Turin 16
Toronto 15
Andover 14
Brooklyn 14
Palermo 14
San Francisco 14
Bologna 13
Falls Church 13
Frankfurt am Main 13
Bern 12
Salerno 12
West Jordan 12
Atlanta 10
Johannesburg 9
Poplar 9
Springfield 9
Venice 9
Bangkok 8
Bari 8
Denver 8
Hải Dương 8
Miano 8
Richmond 8
Rio de Janeiro 8
Washington 8
Yubileyny 8
Ankara 7
Baghdad 7
Erbil 7
Manchester 7
Padua 7
Philadelphia 7
Queens 7
Totale 13.022
Salva come PNG Salva come JPEG
Nome #
Evaluation of traditional and emerging cardiovascular risk factors in patients with non-arteritic anterior ischemic optic neuroparty: a case-control study 420
A meta-analysis of potential risks of of low levels of protein Z for diseases related to vascular thrombosis 381
Usefulness of aspirin resistance after percutaneous coronary intervention for acute myocardial infarction in predicting one-year major adverse coronary events. 368
Angiotensi-converting enzyme DD genotype, angiotensin type 1 receptor CC genotype, and hyperhomocysteinmeia increase first-trimester fetal-loss susceptibility 355
Protein Z gene polymorphisms (intron F 79G>A; -13 A>G) are not associated with acute coronary syndromes 352
Low protein Z levels in patients with peripheral arterial disease 334
Hypercoagulability, high tissue factor and low tissue factor pathway inhibitor levels in severe ovarian hyperstimulation syndrome: possible association with clinical outcome. 308
High lipoprotein (a) levels are associated with an increased risk of retinal vein occlusion 303
Fish intake and LPA 93C>T polymorphism: gene-environment interaction in modulating lipoprotein (a) concentrations 291
D-dimer concentrations during normal pregnancy, as measured by ELISA 289
Homocysteine and tissue factor pathway inhibitor levels in patients with Fabry's disease 282
Lower homocysteine levels in renal transplant recipients treated with everolimus: a possible link with a decreased cardiovascular risk? 281
Modifications of protein Z and interleukin-6 during the acute phase of coronary artery disease 279
Protein Z is not synthesised by human umbilical vein endothelial cells 275
Thrombotic events in high risk patients are predicted by evaluating different pathways of platelet function. 272
D-Dimer in intra-uterine growth retardation and gestational hypertension 269
Protein Z: "Light and Shade" of a new thrombotic factor 267
D-dimer increase after percutaneous transluminal angioplasty and clinical recurrence after primary revascularization in acute myocardial infarction? A pilot study 233
Reduced platelet thromboxane A2 production as a possible cause of defective platelet aggregation in cirrhosis. 223
Fibrinolysis alterations in infertile women during controlled ovarian stimulation: Influence of BMI and genetic components. 215
Antiphospholipid antibodies (aPL) increase the potential monocyte procoagulant activity in patients with systemic lupus erythematosus 211
A hypercoagulable and hypofibrinolytic state is detectable by global methods in patients with retinal vein occlusion. 211
ACE DD genotype: an independent predisposition factor to venous thromboembolism. 210
RISK FACTORS FOR CARDIOVASCULAR DISEASE IN RENAL TRANSPLANT RECIPIENTS: NEW INSIGHTS 205
Activation of the immune system and coronary artery disease: the role of anti-endothelial cell antibodies. 201
Is tissue factor pathway inhibitor a marker of procoagulable status in healthy infertile women undergoing ovarian stimulation for assisted reproduction? 200
Antiphospholipid antibodies and pregnancy disorders in women with insulin dependent diabetes 199
EFFECT OF TOURNIQUET USE ON ACTIVATION OF COAGULATION IN TOTAL KNEE REPLACEMENT 196
D-dimer plasma levels during normal pregnancy measured by specific ELISA 196
TISSUE FACTOR AND HOMOCYSTEINE LEVELS IN ISCHEMIC HEART DISEASE ARE ASSOCIATED WITH ANGIOGRAPHICALLY DOCUMENTED CLINICAL RECURRENCES AFTER CORONARY ANGIOPLASTY 192
Low vitamin B6 and folic acid levels are associated with retinal vein occlusion independently of homocysteine levels. 192
Lp(a): a new risk factor for deep venous thrombosis? 188
Blood clotting activation during normal pregnancy 188
Hyperhomocysteinemia in renal transplant patients as independent cause of endothelial damage and cardiovascular disease. 184
Protein Z plasma levels in different phases of activity of coronary atherosclerosis 182
A proinflammatory state is associated with hyperhomocysteinemia in the elderly 181
Acquired activated protein C resistance in postmenopausal women is dependent on factor VIII:c levels. 179
Percutaneous transluminal coronary angioplasty procedure is associated to a decrease in transforming growth factor beta 1 levels 179
Hemostatic disorders in 25 patients with limited and uncomplicated thyroid and breast cancer: prophylactic and therapeutic considerations 177
Evaluation of clotting and fibrinolytic activation after protracted physical exercise 176
Atherosclerotic and thrombophilic risk factors in patients with ischemic central retinal vein occlusion 176
Electrophysiologic procedures and activation of the hemostatic system 174
Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients. 173
FIBRINOLYTIC PARAMETERS IN YOUNG ADULTS: THE FLOREN-TEEN ( FLORENCE TEENAGER) STUDY 171
Thrombophilias as risk factors for disorders of pregnancy and fetal damage 170
Acute pyhase proteins in alcoholics with or without liver injury 170
Anticoagulant effect of dabigatran, rivaroxaban or apixaban treatment on different laboratory hemostasis tests in patients with atrial fibrillation 170
Platelet and blood clotting activation in patients with mitral valve prolapse 168
Tissue factor and tissue factor pathway inhibitor levels in unstable angina patients during short-term low-molecular-weight heparin administration. 166
Angiotensin converting enzyme DD genotype affects the changes of plasma plasminogen activator inhibitor-1 activity after primary percutaneous transluminal coronary angioplasty in acute myocardial infarction patients 166
Changes in lipid and hemostatic parameters induced by tibolone treatment 166
Evaluation of a new point-of-care celite-activated clotting time analyzer in different clinical settings. The i-STAT celite-activated clotting time test. 164
Activation of the coagulation system during electrophysiologic invasive study with and without ablation 162
Comparison of different methods to evaluate the effect of aspirin on platelet function in high-risk patients with ischemic heart disease receiving dual antiplatelet treatment. 161
Influence of endothelial nitric oxide synthase gene polymorphisms (G894T, 4a4b, T-786C) and hyperhomocysteinemia on the predisposition to acute coronary syndromes 161
Antiphospholipid antibodies : a new risk factor for restenosis after percutaneous transluminal coronary angioplasty? 161
Relatioship between the platelet aggregation of the newborn and mother 160
Effect of temperature and incubation time on D-dimer serum levels in healthy subjects. 160
Protein Z levels and prognosis in patients with acute coronary syndromes 158
Genetic determinants of fasting and post-methionine hyperhomocysteinemia in patients with retinal vein occlusion 158
Vitamin supplementation reduces the progression of atherosclerosis in hyperhomocysteinemic renal-transplant recipients 157
Hyperhomocysteinemia and hypercoagulability in primary biliary cirrhosis. 157
Usefulness of screening for congenital or acquired hemostatic abnormalities in women with previous complicated pregnancies. 156
Alterations of haemorheological parameters in patients with Peripheral Arterial Disease 156
Clottable to immunological fibrinogen ratio in plasma from control subjects and hyperfibrinogenemic patients 153
Thrombophilic risk factors in patients with severe carotid atherosclerosis 152
The influence of smoking on von Willebrand factor is already manifest in healthy adolescent females: the Floren-teen (Florence Teenager) Study. 150
D-dimer plasma levels in pathological pregnancy: use of a rapid test (NycoCard). 150
Increased plasma levels of lipoprotein(a) and the risk of idiopathic and recurrent venous thromboembolism 149
Leisure-time but not occupational physical activity significantly affects cardiovascular risk factors in an adult population 149
Accuracy of a Point-of-Care system for PT/INR test performed in the hospital anticoagulation clinic 147
Hypofibrinolysis accounts only in part for alteration of clot lysis time in patients with prior pulmonary embolism without pulmonary hypertension 146
A mixture of bupivacaine and fentanyl in epidural block in orthopedic surgery: effects on blood coagulation and fibrinolysys 145
High cysteine levels in renal transplant recipients: relationship with hyperhomocysteinemia and 5,10-MTHFR polymorphism. 144
Relevance of post-methionine homocysteine and lipoprotein (a) in evaluating the cardiovascular risk in young CAD patients. 141
Hyperhomocysteinemia in renal transplant patients: an independent factor of cardiovascular disease 139
Tissue factor reduction and tissue factor pathway inhibitor release after heparin administration. 139
Dietary habits, lifestyle and cardiovascular risk factors in a clinically healthy Italian population: the “Florence” diet is not Mediterranean 138
Molecular mechanism underlying impaired platelet responsiveness in liver cirrhosis 138
The role of cysteine and homocysteine in venous and arterial thrombotic disease. 137
Nuovi fattori di rischio per la patologia carotidea 136
Plasma and serum levels of D-dimer and their correlations with other hemostatic parameters in pregnancy. 135
Thrombophilic risk factors in patients with central retinal vein occlusion. 134
Hyperhomocysteinemia in patients with pulmonary embolism is associated with impaired plasma fibrinolytic capacity 131
Homocysteine-lowering therapy and carotid intima-media thickness in renal transplant recipients. 130
High prevalence of anti-beta2 glycoprotein I antibodies in patients with ischemic heart disease 129
Low protein Z levels are independently associated with acute coronary syndromes 129
TAFI activity and antigen plasma levels are not increased in acute coronary artery disease patients admitted to a coronary care unit 128
Coparison of some serum copper parameters in treined runners and control subjects 128
High prevalence of mild hyperhomocysteinemia in patients with abdominal aortic aneurysm 127
Changes in fibrinolysis after primary PTCA 120
Evaluation of the prevalence of severe hyperhomocysteinemia in adult patients with thrombosis who underwent screening for thrombophilia 117
Substance P-induced fibrinolysis in teh forearm of healthy humans 108
Protein Z levels, protein Z G79A polymorphism, and prothrombotic conditions 107
Iperomocisteinemia in pazienti con aneurisma dell’aorta addominale: nuovo fattore patogenetico? 102
Hyperhomocysteinemia and vitamin B6 deficiency: new risk markers for nonvalvular atrial fibrillation? 101
Persistent generation of thrombin after coronary angioplasty 100
Hyperhomocysteinemia and abdominal aortic aneurysm 98
Reliabilitybof Point-of-Care System for PT/INR performed on capillary and citrated whole blood: comparison with conventional laboratory method 95
Omocisteina e malattie cerebrovascolari 95
Totale 18.452
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.187
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.187
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022643 0 0 63 30 36 29 14 48 32 37 165 189
2022/20231.822 177 246 69 163 183 350 258 106 185 7 51 27
2023/2024602 35 73 117 30 32 87 26 134 2 15 32 19
2024/20254.269 122 467 266 671 1.344 498 26 293 218 98 149 117
2025/20264.735 502 661 366 409 580 194 531 220 267 252 78 675
2026/2027794 286 221 287 0 0 0 0 0 0 0 0 0
Totale 19.141